Head and neck cancers, Mouth and oropharyngeal cancer
Results
Other
This study looked at an increased dose of intensity modulated radiotherapy (IMRT) to treat cancer where the mouth joins the throat (the oropharynx).
Doctors call this oropharyngeal cancer. This study was for people whose oropharyngeal cancer wasn’t linked to the human papilloma virus ()
This study was open for people to join between 2012 and 2014. These results were published in 2018.
Recruitment start: 2 November 2012
Recruitment end: 22 January 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paul Sanghera
Queen Elizabeth Hospital Birmingham Charities
University Hospital Birmingham NHS Foundation Trust
Last reviewed: 26 February 2020
CRUK internal database number: 9308
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
